Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-08
2006-08-08
Lambkin, Deborah C. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S468000, C549S298000
Reexamination Certificate
active
07087641
ABSTRACT:
The present invention provides a new class of compounds 4β-1″-[{2″-benzoyl substituted}anilino] podophyllotoxin exhibiting anti cancer activity and a process for preparing the same.
REFERENCES:
patent: 5300500 (1994-04-01), Lee et al.
patent: 5332811 (1994-07-01), Kuo-Hsiung et al.
patent: 6566393 (2003-05-01), Lee et al.
patent: 6713454 (2004-03-01), Ekwuribe et al.
patent: 6872841 (2005-03-01), Lee et al.
patent: 6878746 (2005-04-01), Monneret et al.
Cho et al., “Antitumor Agents 163 Three-Dimensional Quantitative Structure-Activity Relationship Study of 4′-0- Demethylepipodopyllotoxin Analogs Using the CoMFA/q2-GRS Approach,” Journal of Medicinal Chemistry, vol. 39, No. 7, 1996, pp. 1383-1395, XP-002222563.
Kamal Ahmed
Reddy Peram Surakattula Murali Mohan
Council of Scientific & Industrial Research
Foley & Lardner LLP
Lambkin Deborah C.
LandOfFree
4β-1″-[(2″-substituted benzoyl)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4β-1″-[(2″-substituted benzoyl)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4β-1″-[(2″-substituted benzoyl)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3615842